SEHCAT 370 KBQ capsules medication leaflet

V09DX01 selenium (75Se) tauroselcholic acid • Various | Hepatic and reticulo endothelial system | Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals

Selenium (75Se) tauroselcholic acid is a radioactive compound used in imaging studies to evaluate liver and biliary function. It is administered intravenously and tracked using imaging techniques to assess bile flow and liver function.

The medication is used under the supervision of a nuclear medicine specialist, and the dose is adjusted based on the patient's needs. It is important for patients to inform the doctor of any pre-existing conditions or allergies.

Patients should be aware of potential side effects, such as allergic reactions or discomfort at the injection site. It is important to inform the doctor of any unusual symptoms.

Common side effects include discomfort at the injection site and mild allergic reactions. In rare cases, severe reactions such as hypersensitivity may occur. Patients should be informed of these risks before administration.

General data about SEHCAT 370 KBQ

Substance: selenium (75Se) tauroselcholic acid

Date of last drug list: 01-09-2023

Commercial code: W69711001

Concentration: 370kBq

Pharmaceutical form: capsules

Quantity: 1

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: GE HEALTHCARE BUCHLER GMBH & CO. KG - GERMANIA

Holder: GE HEALTHCARE BUCHLER GMBH & CO. KG - GERMANIA

Number: 15075/2023/01

Shelf life: 18 saptamâni-after packing for marketing;12 saptamâni-data de referinta înscrisa pe eticheta